Laboratorio Reig Jofre S.A. is a pharmaceutical and health products company engaged in the manufacturing, research, development, and commercialization of pharmaceuticals, biotechnological products, nutritional supplements, medical devices, cosmetics, and food products. The company operates through the production of pharmaceutical specialties for both its own commercialization and third-party clients, alongside the provision of research and development services. Its business activities include the import, export, and wholesale and retail distribution of authorized dietary supplements, dietetic products, and cosmetics. Additionally, the group focuses on the elaboration and research of active principles and nutraceutical ingredients derived from natural sources, aimed at disease prevention or nutritional supplementation in functional foods, with a focus on patenting and licensing these innovations to third parties.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Drug Manufacturers - General Homepage reigjofre.com
Sector Healthcare IR page reigjofre.com/en/investors
Tags
pharmaceuticals, nutraceuticals, medical devices, cosmetics, dietetic products, research and development, licensing, functional foods
Press page —

Metrics

Valuation  
Market cap € 221.761M
Market cap (USD) $ 245.09M
P/E 33.13
PEG —
P/BV 0.99
P/S 0.67
P/OCF 238.45
P/FCF -16.10
Dividend yield 12.1%
Turnover / mcap —
Returns  
ROE 2.3%
ROI 2.2%
ROIC 1.5%
Profit margin 1.5%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -14.8%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -38.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 331.097M 338.895M 316.088M 271.15M 236.231M 230.079M 200.207M 180.468M 167.983M 161.134M 156.91M 33.284M 31.37M 29.926M 29.485M 38.841M
Net profit 4.998M 10.467M 9.397M 8.106M 5.08M 5.666M 4.939M 9.253M 8.811M 7.667M 8.75M 2.311M 953K -6K 16.066M -22.618M
Free cash flow -13.776M 11.076M 6.652M 5.201M -4.728M 18.381M 5.832M — — — — — — — — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price — — 2.7 2.7 — — — — — — — — — — — —
P/FCF — — 31.82 42.09 — — — — — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (EUR) 40.5M 42.6M 44.4M 49.8M 55.9M 56M 65.3M
↳ YoY growth +5.1% +4.2% +12.1% +12.2% +0.3% +16.5%
↳ 5y CAGR +6.7% +8.9%
Lease liabilities (EUR) 41.2M 20.9M 20M 17.3M 14.7M 12.5M 21.1M
Cash and deposits (EUR) 10.2M 11.6M 5.07M 6.45M 5.53M 10.5M 10.5M
Intangible assets (EUR) — 82.8M 77.7M 70.9M 63.1M 55.3M 69.6M
Cash flow detail
Operating cash flow (EUR) 11.7M 22.5M 14.5M 16.1M 19.1M 31.3M 1.51M
Purchases of property, plant and equipment (EUR) -5.85M -4.12M -19.2M -10.9M -12.5M -20.3M -15.3M
Purchases of intangible assets (EUR) -25.3M -11.7M -537,000 -453,000 -307,000 -519,000 -3.01M
Change in receivables (cash effect) (EUR) -8.56M -1.39M -1.75M -3.08M -4.73M -1.23M -6.94M
Change in inventories (cash effect) (EUR) -4.1M -3M -7.11M -1.06M -13.9M -2.07M 2.53M
Change in payables (cash effect) (EUR) 6.32M 1.45M 1.85M 855,000 6.85M -254,000 -9.91M
Dividends paid (cash effect) (EUR) -359,000 -88,000 -55,000 -53,000 -41,000 -25,000 -32,000
Share buybacks (cash effect) (EUR) -238,000 -628,000 -753,000 -363,000 -20,000 -3,000 -79,000
Interest paid (cash effect) (EUR) -1.05M -990,000 -883,000 -1.04M -1.23M -1.98M -1.65M
Income taxes paid (cash effect) (EUR) -1.33M -1.64M -913,000 -883,000 -1.47M 289,000 743,000
Operating cash flow before change in receivables (EUR) 20.2M 23.9M 16.2M 19.2M 23.8M 32.6M 8.45M
Free cash flow (OCF - PPE - intangibles) (EUR) -19.5M 6.64M -5.27M 4.75M 6.35M 10.6M -16.8M
Income detail
Total comprehensive income (EUR) 4.99M 5.98M 5.1M 6.54M 9.8M 10.3M 6.02M
Comprehensive income to owners (EUR) 4.99M 5.98M 5.11M 6.54M 9.81M 10.2M 6.04M
Reported Feb 26, 2021 Mar 7, 2022 Mar 7, 2022 Feb 28, 2023 Feb 29, 2024 Feb 28, 2025 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

LABORATORIO REIG JOFRE S.A. (ticker RJF), listed in Spain.

ETFs Holding LABORATORIO REIG JOFRE S.A.

ETF Weight in ETF Shares Market value As of
DISV 0.00% 884 $ 2,582.65 Nov 12, 2026
DFIC 0.00% 20 $ 58.43 Nov 12, 2026